{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreigqeyapmcrin3xalqp4wvpf3yf5ptpsr5snfc3tihzkslvrv4hmh4",
    "uri": "at://did:plc:6pwit4ctv4egvys3qyqmgbi6/app.bsky.feed.post/3mmbs4kfu5pv2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreignyxeynrnrnfkjenfanu7qocsubrkh546kfue7ypaqxgbdxx4z6y"
    },
    "mimeType": "image/jpeg",
    "size": 57001
  },
  "path": "/health/new-drug-approach-offers-hope-patients-recurrent-aggressive-cancers",
  "publishedAt": "2026-05-20T11:00:20.000Z",
  "site": "https://www.foxnews.com",
  "tags": [
    "fda3da0a-ae39-53a2-a7d6-d4f5f15dcc67",
    "fnc",
    "Fox News",
    "fox-news/health",
    "fox-news/health/cancer",
    "fox-news/health/medical-research",
    "fox-news/health/medical-research/cancer-research",
    "fox-news/health/healthy-living/womens-health",
    "fox-news/lifestyle",
    "fox-news/health/healthy-living/medications",
    "article"
  ],
  "textContent": "Merck announces that sac-TMT, a new cancer drug, demonstrated strong results in phase 3 trials for advanced or recurrent endometrial cancer patients.",
  "title": "New drug approach offers hope for patients with recurrent aggressive cancers"
}